Aug 15, 2023 / 12:00PM GMT
Operator
Good morning, everyone, and welcome to the Freeline's second-quarter 2023 financial and business update conference call. (Operator Instructions) Please also note today's event is being recorded. At this time, I'd like to turn the floor over to Naomi Aoki, SVP of Investor Relations and Corporate Communications. Ma'am, you may begin.
Naomi Aoki - Freeline Therapeutics Holdings plc - SVP, Head of IR & Corporate Communications
Thank you, operator, and thanks to everyone for joining us on the call. Earlier today, we issued a press release and filed our quarterly reports on Form 6-K with our second quarter 2023 financial results and business updates. The release and 6-K are both available on the Investors section of our website.
We'll begin the call with prepared remarks by Michael Parini, our Chief Executive Officer; Pamela Foulds, our Chief Medical Officer; and Paul Schneider, our Chief Financial Officer; Rose Sheridan, our SVP of Research is also on the call and will be available for Q&A. Before we begin, I would like to remind everyone that we
Q2 2023 Freeline Therapeutics Holdings PLC Earnings Call Transcript
Aug 15, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers